310 related articles for article (PubMed ID: 28301691)
1. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
[TBL] [Abstract][Full Text] [Related]
2. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa.
Schlapbach C; Hänni T; Yawalkar N; Hunger RE
J Am Acad Dermatol; 2011 Oct; 65(4):790-798. PubMed ID: 21641076
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa.
Thomi R; Kakeda M; Yawalkar N; Schlapbach C; Hunger RE
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2091-2096. PubMed ID: 28602023
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
[TBL] [Abstract][Full Text] [Related]
7. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
[TBL] [Abstract][Full Text] [Related]
8. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
9. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
[TBL] [Abstract][Full Text] [Related]
10. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
[TBL] [Abstract][Full Text] [Related]
11. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-17 in the pathogenesis of hidradenitis suppurativa.
Yao Y; Thomsen SF
Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469692
[TBL] [Abstract][Full Text] [Related]
13. IL-36 cytokines are increased in acne and hidradenitis suppurativa.
Di Caprio R; Balato A; Caiazzo G; Lembo S; Raimondo A; Fabbrocini G; Monfrecola G
Arch Dermatol Res; 2017 Oct; 309(8):673-678. PubMed ID: 28852851
[TBL] [Abstract][Full Text] [Related]
14. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.
Vossen ARJV; van der Zee HH; Davelaar N; Mus AMC; van Doorn MBA; Prens EP
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):761-765. PubMed ID: 30451329
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.
Campanati A; Orciani M; Sorgentoni G; Consales V; Offidani A; Di Primio R
JAMA Dermatol; 2018 Oct; 154(10):1184-1190. PubMed ID: 30140888
[TBL] [Abstract][Full Text] [Related]
16. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of the antimicrobial peptide LL-37 in hidradenitis suppurativa are associated with a Th1/Th17 immune response.
Thomi R; Schlapbach C; Yawalkar N; Simon D; Yerly D; Hunger RE
Exp Dermatol; 2018 Feb; 27(2):172-177. PubMed ID: 29222824
[TBL] [Abstract][Full Text] [Related]
18. Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
[TBL] [Abstract][Full Text] [Related]
19. Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis.
Thomi R; Cazzaniga S; Seyed Jafari SM; Schlapbach C; Hunger RE
JAMA Dermatol; 2018 May; 154(5):592-595. PubMed ID: 29617527
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy.
Moran B; Sweeney CM; Hughes R; Malara A; Kirthi S; Tobin AM; Kirby B; Fletcher JM
J Invest Dermatol; 2017 Nov; 137(11):2389-2395. PubMed ID: 28652108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
